Researcher.Life Logo

Wspolczesna Onkologia : Impact Factor & More

eISSN: 1897-4309pISSN: 1428-2526
JournalOpen Access

Key Metrics

CiteScore
2.8
SJR
Q3Oncology
SNIP
0.61
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Wspolczesna Onkologia

Wspolczesna Onkologia Journal Specifications

Overview
Publisher TERMEDIA PUBLISHING HOUSE LTD
Language English
Frequency Quarterly
Article Processing ChargesEUR 200
Publication Time24
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1987
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 24
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC-SA
OA statementVisit website
View less

Planning to publish in Wspolczesna Onkologia ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Wspolczesna Onkologia

Serum citrulline as a prognostic marker in patients with oropharyngeal carcinoma treated with chemoradiotherapy.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Best supportive care in patients with brain metastases: impact of the primary tumour type on survival.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Combined analysis of metabolomics and transcriptomics reveals new indicators for the diagnosis and prognosis of colorectal cancer.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
In silico approach and in vitro study of fangchinoline-induced apoptosis and reactive oxygen species production in HER2-overexpressing breast cancer cells.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Retracted: Evaluation of morphology and angiogenesis of breast cancer in BALB/c mice using trypsin inhibitor from Cucumis melo seeds. In vitro and in vivo study.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Diagnosis, prognostic prediction of the accelerated phase of chronic lymphocytic leukaemia: a narrative review.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Serum citrulline as a prognostic marker in patients with oropharyngeal carcinoma treated with chemoradiotherapy.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Best supportive care in patients with brain metastases: impact of the primary tumour type on survival.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Combined analysis of metabolomics and transcriptomics reveals new indicators for the diagnosis and prognosis of colorectal cancer.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
In silico approach and in vitro study of fangchinoline-induced apoptosis and reactive oxygen species production in HER2-overexpressing breast cancer cells.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Retracted: Evaluation of morphology and angiogenesis of breast cancer in BALB/c mice using trypsin inhibitor from Cucumis melo seeds. In vitro and in vivo study.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)
Diagnosis, prognostic prediction of the accelerated phase of chronic lymphocytic leukaemia: a narrative review.
  • 1 Jan 2026
  • Contemporary oncology (Poznan, Poland)

FAQs on Wspolczesna Onkologia